Plant-part clarity
Guides identify the difference between fruit, seed, leaf, root bark, and processed preparations instead of treating “iboga” as one uniform material.
Independent information resource
Services
Clear, tissue-specific guides for people trying to separate iboga fruit from root bark, broad plant claims from compound evidence, and curiosity from avoidable risk.
Evidence before claims
What Pithmark provides
Information, not intervention.
Pithmark offers plain-language tools for evaluating what a product description actually says—and what it does not establish. The focus is on distinctions that matter before anyone assumes an iboga fruit product is psychoactive, comparable to root bark, or predictable in effect.
Claim checks
Comparison tools separate a seller’s wording from evidence about the named tissue, compound, extract, or preparation.
Research summaries
Short explainers make room for uncertainty, including when evidence is limited, indirect, or specific to a different plant material.
Risk context
Safety content keeps serious uncertainty visible rather than allowing botanical language to imply that a product is low-risk.
The central comparison
Fruit is not a shortcut for root bark.
Our comparisons begin with the simplest useful question: which plant tissue is actually being discussed? That question matters because plant parts and preparations should not be presumed interchangeable.
The genus is commonly discussed in relation to Tabernanthe iboga, but a shared botanical name does not turn every tissue or product into the same chemical material. Pithmark’s fruit-versus-root comparison is built to slow down that leap.
For the larger orientation, our iboga fruit overview sets out the same evidence-first approach: identify the material, identify the claim, then identify what has actually been established.
Four information services
Tools for making claims legible.
These are reading and comparison resources. They do not diagnose, prescribe, recommend products, or replace medical or legal advice.
In-depth guides
Focused explainers map the language around iboga fruit, root bark, alkaloids, extracts, and product descriptions so readers can see where a broad label stops being precise.
Decision frameworks
Practical question sets help readers inspect tissue identity, preparation, testing language, evidence limits, and risk signals before treating a claim as meaningful.
Research summaries
Plain-language summaries distinguish findings about specific compounds from assumptions about a fruit or consumer product. The testing explainer shows why a label alone cannot establish composition.
Glossary and FAQ
Definitions and recurring questions keep key terms usable without promotional framing. Our approach and scope explain why Pithmark treats evidence limits as part of the answer, not an afterthought.
A repeatable reading method
Start with the material.
The method is intentionally basic. It prevents a broad plant name, a vivid anecdote, or an unverified listing from doing more evidentiary work than it can support.
Name the tissue
Ask whether a claim identifies fruit, root bark, seed, leaf, a mixture, or an extract. If it does not, precision is already missing.
Name the evidence
Check whether the statement concerns the exact material in question, rather than a related compound or a different preparation.
Keep risk visible
Do not let an ambiguous composition claim become a safety conclusion. The consumer risk material keeps that boundary explicit.
Frequently asked questions
Useful limits.
These answers describe the scope of the resource. They are not individual guidance for using, buying, or combining any substance.
Do these information services tell people what to take?
No. Pithmark distinguishes plant parts, product claims, and safety uncertainty. It does not provide personal medical direction, dosage instructions, or treatment recommendations. The FDA’s drug safety information similarly reflects why safety questions should not be reduced to marketing language.
Why separate fruit from root bark?
Plant tissues are not interchangeable. A clear comparison helps readers avoid treating a label or a broad plant name as evidence that products share the same composition or effects.
What does “psychoactive” establish?
It describes the capacity of a substance to affect mental processes; it does not establish the composition, dose, safety, or expected effect of a particular product. That distinction is central to the meaning of psychoactive substances and to careful product interpretation.
Where can people find treatment-specific information?
Pithmark is not a treatment provider. For material framed around treatment settings, consult Ibogaine Treatment Centers Europe directly and evaluate its information separately from this independent resource.
“A plant name is not a composition report, and a composition claim is not a safety conclusion.”
Keep the distinction in view.
Use Pithmark’s information resources to approach iboga fruit claims with a clearer vocabulary, a sharper comparison method, and room for serious uncertainty.
Compare fruit and root